These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases]. Ayed K; Gorgi Y; Sfar I; Khrouf M Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933 [TBL] [Abstract][Full Text] [Related]
4. [Neonatal lupus syndrome: Literature review]. Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481 [TBL] [Abstract][Full Text] [Related]
5. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block. Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310 [TBL] [Abstract][Full Text] [Related]
6. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block. Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891 [TBL] [Abstract][Full Text] [Related]
7. Neonatal lupus: bedside to bench and back. Buyon JP Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918 [TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers. Izmirly P; Kim M; Friedman DM; Costedoat-Chalumeau N; Clancy R; Copel JA; Phoon CKL; Cuneo BF; Cohen RE; Robins K; Masson M; Wainwright BJ; Zahr N; Saxena A; Buyon JP J Am Coll Cardiol; 2020 Jul; 76(3):292-302. PubMed ID: 32674792 [TBL] [Abstract][Full Text] [Related]
9. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block. Skog A; Lagnefeldt L; Conner P; Wahren-Herlenius M; Sonesson SE Acta Obstet Gynecol Scand; 2016 Jan; 95(1):98-105. PubMed ID: 26411741 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. Buyon JP; Hiebert R; Copel J; Craft J; Friedman D; Katholi M; Lee LA; Provost TT; Reichlin M; Rider L; Rupel A; Saleeb S; Weston WL; Skovron ML J Am Coll Cardiol; 1998 Jun; 31(7):1658-66. PubMed ID: 9626848 [TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Brucato A; Cimaz R; Caporali R; Ramoni V; Buyon J Clin Rev Allergy Immunol; 2011 Feb; 40(1):27-41. PubMed ID: 20012231 [TBL] [Abstract][Full Text] [Related]
12. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy. Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700 [TBL] [Abstract][Full Text] [Related]
13. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block. Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164 [TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Brucato A; Doria A; Frassi M; Castellino G; Franceschini F; Faden D; Pisoni MP; Solerte L; Muscarà M; Lojacono A; Motta M; Cavazzana I; Ghirardello A; Vescovi F; Tombini V; Cimaz R; Gambari PF; Meroni PL; Canesi B; Tincani A Lupus; 2002; 11(11):716-21. PubMed ID: 12475001 [TBL] [Abstract][Full Text] [Related]
15. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'. Scarsi M; Radice A; Pregnolato F; Ramoni V; Grava C; Bianchi L; Gerosa M; Mosca M; Ghirardello A; Tani C; Motta M; Quinzanini M; Tincani A; Ruffatti A; Migliorini P; Doria A; Meroni PL; Brucato A Clin Exp Rheumatol; 2014; 32(6):848-54. PubMed ID: 25327946 [TBL] [Abstract][Full Text] [Related]
17. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block. Lisney AR; Szelinski F; Reiter K; Burmester GR; Rose T; Dörner T Ann Rheum Dis; 2017 Aug; 76(8):1476-1480. PubMed ID: 28501799 [TBL] [Abstract][Full Text] [Related]
18. Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block. Tonello M; Ruffatti A; Marson P; Tison T; Marozio L; Hoxha A; De Silvestro G; Punzi L Transfusion; 2015 Jul; 55(7):1782-6. PubMed ID: 25825254 [TBL] [Abstract][Full Text] [Related]
19. Congenital heart block related to maternal autoantibodies: descriptive analysis of a series of 18 cases from a single center. Doti PI; Escoda O; Cesar-Díaz S; Palasti S; Teixidó I; Sarquella-Brugada G; Gómez O; Martínez JM; Espinosa G Clin Rheumatol; 2016 Feb; 35(2):351-6. PubMed ID: 26791874 [TBL] [Abstract][Full Text] [Related]
20. Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective. Friedman DM; Rupel A; Glickstein J; Buyon JP Indian J Pediatr; 2002 Jun; 69(6):517-22. PubMed ID: 12139139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]